Zymeworks ZYME 深 滬
等待開盤 09-17 09:30:00 美东时间
26.24
+0.190
+0.73%
華盛通- 最 高26.55
- 今 開26.17
- 成交量 68.70万股
- 最 低 25.91
- 昨 收 26.05
- 總市值 18.62亿
- 52周最高 31.34
- 市盈率 靜 --
- 換手率 0.97%
- 52周最低 16.0034
- 委 比 -91.73%
- 總股本 7095.92万
- 歷史最高 59.03
- 量 比 1.05
- 振 幅 2.46%
- 歷史最低 4.11
- 每 手 1
- 風險率 3.35%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Catalyst Watch: FOMC blockbuster, Salesforce event, and 24-hour trading talk
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - September...
09-12 03:00
Theravance facing several lawsuits seeking to block Zymeworks acquisition
Theravance Biopharma (TBPH) is facing at least three lawsuits that aim to scuttle its planned $929M acquisition by Zymeworks (ZYME). The legal actions seek to enjoin Theravance from proceeding with th...
09-10 23:03
Theravance Biopharma issues disclosures amid Zymeworks merger
Theravance Biopharma ( ($TBPH) ) just unveiled an update. On June 28, 2026, The...
09-10 21:27
美股大行评级 | 大行齐上调AI应用股目标价！Adobe、CRWD等获看好，慧与科技绩后现多空分歧
今日重点评级关注：BTIG：维持Climb Bio"买入"评级，目标价从20美元升至32美元；巴克莱：维持Alpha Tau Medical"超配"评级，目标价从17美元升至30美元
09-04 12:30
JP Morgan Maintains Overweight on Zymeworks, Raises Price Target to $33
JP Morgan analyst Brian Cheng maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $31 to $33.
09-04 05:11
Jazz Pharmaceuticals prices upsized $1.1B private debt offering
Jazz Pharmaceuticals (JAZZ) announced the pricing of $1.1B aggregate principal amount of 1.875% exchangeable senior notes due 2032. The offering was upsized from the previously announced offering size...
08-27 16:28
美股大行评级 | 潜在涨幅1849.95%！Ascendiant Capital上调IGC Pharma目标价至6美元，维持"买入"评级；迪克体育、财捷遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.5美元升至6美元；Ascendiant Capital：维持Quantum Computing"买入"评级，目标价从30美元升至32美元
08-27 08:37
Zymeworks moves higher as Street cheers Ziihera regimen approval
Zymeworks (ZYME) is trading ~8% higher Wednesday as some Street analysts voiced bullish sentiments for the stock after the FDA on Tuesday approved two regimens containing Jazz Pharmaceuticals' (JAZZ) ...
08-26 23:19
MongoDB To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised the price target for Intuit Inc (NASDAQ:INTU) from $250 to $290. Piper Sandler analyst Bi...
08-26 21:26
HC Wainwright & Co. Maintains Buy on Zymeworks, Raises Price Target to $55
HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $51 to $55.
08-26 18:12
